$66.1 Million is the total value of 72 Investment Holdings, LLC's 2 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
RXDX | New | PROMETHEUS BIOSCIENCES INC | $33,745,000 | – | 1,848,024 | +100.0% | 51.02% | – |
PRAX | PRAXIS PRECISION MEDICINES I | $32,399,000 | -40.5% | 988,995 | 0.0% | 48.98% | +568.1% | |
PLTR | Exit | PALANTIR TECHNOLOGIES INCcl a | $0 | – | -29,203,752 | -100.0% | -92.67% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
PRAXIS PRECISION MEDICINES I | 12 | Q3 2023 | 49.0% |
PROMETHEUS BIOSCIENCES INC | 9 | Q1 2023 | 93.9% |
CARIBOU BIOSCIENCES INC | 9 | Q3 2023 | 15.7% |
OMEGA THERAPEUTICS INC | 9 | Q3 2023 | 15.4% |
ENTRADA THERAPTEUTICS INC | 8 | Q3 2023 | 60.0% |
WEWORK INC | 2 | Q1 2022 | 0.2% |
PALANTIR TECHNOLOGIES INC | 1 | Q4 2020 | 92.7% |
TURNSTONE BIOLOGICS CORP | 1 | Q3 2023 | 14.5% |
View 72 Investment Holdings, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View 72 Investment Holdings, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.